6C, D), suggesting that, at least in the initial phase of treatment, these compounds drive their weight-lowering effects mostly by reducing food consumption, without inducing thermogenic responses
GLP-1 medications could become one more tool in this process, particularly for clients whose cravings remain intense even after psychiatric stabilization and initial detox
Participants randomized to retatrutide initiated treatment with 2 mg once weekly and increased the dose in a stepwise approach every four weeks until reaching the target dose of 9 mg (via steps at 2 mg, 4 mg, and 6 mg) or 12 mg (via steps at 2 mg, 4 mg, 6 mg, and 9 mg)
On intraoral examination a bluish black discoloration of about 0.50.3 cm which extends from the marginal gingiva towards the attached gingiva between 11 and 21 regions was noted
Every patient responds differently, and factors like your starting dose, dosage adjustments, lifestyle, and unique body chemistry can influence how quickly you see results